In iA549 cells, the preferential association of the proliferation-associated protein signature with increased RANBP9 expression was consistent with the increased BP9/BP10 ratio observed in CPTAC NSCLC patients (Fig. 8E-G). The gene discussed is RANBP9; the disease is non-small cell lung carcinoma.